Study Stopped
Not enough participants were recruited for a quality study
Study of the Influence of POLD Manual Therapy in Fibromyalgia
Study of the Influence of Manual Therapy According to the POLD Method Within a Pain Treatment Program in Fibromyalgia
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This clinical research aims to study the effects of the introduction of POLD manual therapy within the protocol of fibromyalgia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedJune 29, 2025
June 1, 2025
6 months
May 2, 2019
June 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Demographic data
The following data will be recorded: age, sex, race, children, study start date and final date.
Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Level of Pain: VAS
We will use the Visual Analog Pain Scale (VAS), consisting of a line of 10 cm, whose left end coincides with the value 0 (absence of pain) and the right end with the value 10 (maximum pain imaginable), without reference marks intemediate The patient will mark a point in the line corresponding to his pain at the time of the test, the measurement of the centimeters from the left edge will indicate the analogical score of his pain between 0 and 10.
Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Quality of pain: The Mc Gill pain questionnaire
The Mc Gill pain questionnaire comprises 62 descriptors distributed in 15 classes and, in turn, in 3 dimensions (sensory, affective and evaluative). A value of pain is obtained for each dimension: sensory pain intensity (VID (S), affective pain intensity (VID (A)) and evaluative pain intensity (VID (E)) The sensory component is evaluated in 7 subclasses. The patient mark one or no descriptor of each subclass, if he scores 1 he scores 1 and if he does not mark none he scores 0. The score of the VID (S) is obtained adding and will be, therefore, between 0 and 7. The affective dimension includes subclasses 8 to 13 and its score ranges from 0 to 6. The evaluative dimension corresponds to subclass 14 and the score of it will be 0 or 1. From the sum of the three, the total score (VID (T)) is obtained, from 0 to 14. In addition, the current pain intensity (VIA) is scored from subclass 15, the score is 0-no pain, 1-mild, 2-annoying, 3-intense, 4-strong, 5-unbearable.
Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Pain interference: We use the Brief Pain Inventory
We use the Brief Pain Inventory that gives two main scores: a pain severity score and a pain interference score. The pain severity score is calculated from the four items about pain intensity. Each item is rated from 0, no pain, to 10, pain as bad as you can imagine, and contributes with the same weight to the final score, ranging from 0 to 40. The pain interference score corresponds to the item on pain interference. The seven sub items are rated from 0, does not interfere, to 10, completely interferes, and contributes with the same weight to the final score, ranging from 0 to 70. The first item, pain drawing diagrams (painful and most painful areas) do not contribute to the scoring
Participants will be followed for the duration of treatment application, an expected average of 8 weeks.
Study Arms (2)
POLD concept treatment
EXPERIMENTALPatients treated with rhythmic mobilizations according to the POLD concept, in addition to the standart treatment
CONTROL
ACTIVE COMPARATORPatients treated with the standart treatment
Interventions
STANDART 1. Physical exercise: degreed joint mobilization, self muscle elongation and postural correction. 2. Sophrology: mental control of insomnia and painful perception 3. Cognitive behavioral therapy: analysis of non-assertive relationship patterns or dependence, dysfunctional beliefs, as well as their consequences, psychoeducation of the disease. Strategies for pain management, anxiety, assertiveness and acceptance of the disease POLD 1. Rhythmic transversal muscle mobilization in posterior chain musculature. 2. General vertebral decompression from the sacrum and pelvis 3. Metameric subcutaneous mobilization 4. Rhythmic vertebral mobilization from the spinous processes.
STANDART 1. Physical exercise: degreed joint mobilization, self muscle elongation and postural correction. 2. Sophrology: mental control of insomnia and painful perception 3. Cognitive behavioral therapy: analysis of non-assertive relationship patterns or dependence, dysfunctional beliefs, as well as their consequences, psychoeducation of the disease. Strategies for pain management, anxiety, assertiveness and acceptance of the disease
Eligibility Criteria
You may qualify if:
- Patients diagnosed with Fibromyalgia
- Patients over 25 years old and up to 65 years old, regardless of whether they are women or men.
- Patients who present pain with a minimum value of 5 on the numerical pain scale from 0 to 10, at the time of beginning the study.
- Presence of these symptoms in a long period (more than 6 months)
You may not qualify if:
- Patients with a recent traumatic history.
- Presence of an irradiation component of neurological origin to upper or lower limbs
- Patients with neurological alterations, both central and peripheral.
- Patients who are taking opioid-based analgesic medication.
- Patients with severe spinal malformations.
- That they are following any other type of treatment, whether manual or physical agents or alternative or complementary therapies.
- That they have been treated with infiltrations or similar in a period of less than one year before beginning the study.
- Patients with a serious psychiatric history such as schizophrenia or psychopathies.
- Patients who have vestibular problems that do not tolerate oscillation.
- Patients with heart failure
- Existence of judicial process of disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Omphis Foundationlead
- Universitat de Lleidacollaborator
Study Sites (1)
Specialized hospital unit of fibromyalgia and SD of conical fatigue of L'Hospital Universitari de Santa María (GSS)
Lleida, Catalonia, 25198, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carmen Campoy, PHD
Universitat se Lleida
- STUDY DIRECTOR
Juan Vicente López Díaz, PHD
Universitat de Lleida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
May 2, 2019
First Posted
May 6, 2019
Study Start
July 1, 2024
Primary Completion
December 30, 2024
Study Completion
March 30, 2025
Last Updated
June 29, 2025
Record last verified: 2025-06